TYVANTRA Trademark

Trademark Overview

On Friday, April 1, 2011, a trademark application was filed for TYVANTRA with the United States Patent and Trademark Office. The USPTO has given the TYVANTRA trademark a serial number of 79103488. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Thursday, April 1, 2021. This trademark is owned by Merck Sharp & Dohme Corp. The TYVANTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of migraine
tyvantra

General Information

Serial Number79103488
Word MarkTYVANTRA
Filing DateFriday, April 1, 2011
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateThursday, April 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations for the treatment of migraine

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, April 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme Corp
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressUS

Trademark Events

Event DateEvent Description
Saturday, October 30, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, October 29, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, February 19, 2016NEW REPRESENTATIVE AT IB RECEIVED
Sunday, June 30, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, June 5, 2013FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, June 5, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, April 20, 2013NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, March 27, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 27, 2013NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, June 5, 2012ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, June 5, 2012ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sunday, November 27, 2011REFUSAL PROCESSED BY IB
Thursday, November 10, 2011NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 8, 2011REFUSAL PROCESSED BY MPU
Tuesday, November 8, 2011NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, November 7, 2011NON-FINAL ACTION WRITTEN
Tuesday, November 1, 2011APPLICATION FILING RECEIPT MAILED
Friday, October 28, 2011ASSIGNED TO EXAMINER
Friday, October 28, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 27, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

tyvantra migraine treatment preparations pharmaceutical